Abstract

We herewith cordially invite you to the 14th Congress of the European Headache Society in Berlin. New and exciting times are dawning, with a slew of new therapies underway: CGRP antibodies for migraine prophylaxis, lasmiditan as an alternative to triptans for acute therapy, atogepant, ubrogepant, possibly PACAP antibodies and more. That is why we chose “Head over Ache - Silver Lining Novel Treatments” for the motto of the 14th European Headache Federation Congress. Now we, physicians, psychologists, cost bearers, politicians, and those working in health care, must make sure that the new as well as the old treatments reach the right patients in the optimal way. We therefore invite doctors and scientists from Europe and abroad, but also our partners EFIC, EAN, WONCA, EMA, and WHO to take part in this event. The scientifi c committee will be co-chaired by Professor Richard Lipton, US. We warmly welcome you to the Maritim Hotel from 3–5 July 2020 in wonderful Berlin, which is always worth a visit, especially at the beginning of summer! Together, let’s explore the future of headache treatment here in the capital of Germany. I remain in anticipation of interesting contributions and a profi table discussion